Skip to main content
. 2023 Feb 7;16(2):254. doi: 10.3390/ph16020254

Table 1.

The anticancer activity of 1,3,4-oxadiazole Compound (99).

Cell Line Type of Cancer (s) IC50 (µM) IC50 (µM) Sorafenib
PC-3 Prostate 0.67 1.99
HCT-116 Colon 0.80 1.58
ACHN Renal 0.87 2.51